B cell-derived exosomes can present allergen peptides and activate allergen-specific T cells to proliferate and produce TH2-like cytokines

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 6, 2007, Pages 1418-1424

  Admyre, Charlotte ^a   Bohle, Barbara ^b   Johansson, Sara M ^a   Focke Tejkl, Margarete ^b   Valenta, Rudolf ^b   Scheynius, Annika ^a   Gabrielsson, Susanne ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Center for Physiology and Pathophysiology   (Austria)

Author keywords

allergy; B cells; Bet v 1; Exosomes; T cells

Indexed keywords

ALLERGEN; CD19 ANTIGEN; CD81 ANTIGEN; CD86 ANTIGEN; CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 15; POLLEN ANTIGEN; TETRASPANIN;

ANTIGEN BINDING; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; BIRCH; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOSOME; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PHENOTYPE; POLLEN ALLERGY; PRIORITY JOURNAL; SUPERNATANT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH2 CELL;

ALLERGENS; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTE SUBSETS; BETULA; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CYTOKINES; EPITOPES, T-LYMPHOCYTE; HUMANS; PEPTIDES; POLLEN; T-LYMPHOCYTE SUBSETS; TH2 CELLS; TRANSPORT VESICLES;

EID: 36848999329     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.06.040     Document Type: Article

References (41)

1. Zitvogel L., Regnault A., Lozier A., Wolfers J., Flament C., Tenza D., et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 4 (1998) 594-600
2. Blanchard N., Lankar D., Faure F., Regnault A., Dumont C., Raposo G., et al. TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex. J Immunol 168 (2002) 3235-3241
3. Raposo G., Nijman H.W., Stoorvogel W., Liejendekker R., Harding C.V., Melief C.J., et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183 (1996) 1161-1172
4. Raposo G., Tenza D., Mecheri S., Peronet R., Bonnerot C., and Desaymard C. Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol Biol Cell 8 (1997) 2631-2645
5. Heijnen H.F., Schiel A.E., Fijnheer R., Geuze H.J., and Sixma J.J. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94 (1999) 3791-3799
6. van Niel G., Raposo G., Candalh C., Boussac M., Hershberg R., Cerf-Bensussan N., et al. Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology 121 (2001) 337-349
7. Wolfers J., Lozier A., Raposo G., Regnault A., Thery C., Masurier C., et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 7 (2001) 297-303
8. Clayton A., Court J., Navabi H., Adams M., Mason M.D., Hobot J.A., et al. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J Immunol Methods 247 (2001) 163-174
9. Escola J.M., Kleijmeer M.J., Stoorvogel W., Griffith J.M., Yoshie O., and Geuze H.J. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem 273 (1998) 20121-20127
10. Admyre C., Grunewald J., Thyberg J., Gripenback S., Tornling G., Eklund A., et al. Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid. Eur Respir J 22 (2003) 578-583
11. Pisitkun T., Shen R.F., and Knepper M.A. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A 101 (2004) 13368-13373
12. Andre F., Schartz N.E., Movassagh M., Flament C., Pautier P., Morice P., et al. Malignant effusions and immunogenic tumour-derived exosomes. Lancet 360 (2002) 295-305
13. Caby M.P., Lankar D., Vincendeau-Scherrer C., Raposo G., and Bonnerot C. Exosomal-like vesicles are present in human blood plasma. Int Immunol 17 (2005) 879-887
14. Admyre C., Johansson S.M., Qazi K.R., Filen J.J., Lahesmaa R., Norman M., et al. Exosomes with immune modulatory features are present in human breast milk. J Immunol 179 (2007) 1969-1978
15. Johnstone R.M., Adam M., Hammond J.R., Orr L., and Turbide C. Vesicle formation during reticulocyte maturation: association of plasma membrane activities with released vesicles (exosomes). J Biol Chem 262 (1987) 9412-9420
16. Admyre C., Johansson S.M., Paulie S., and Gabrielsson S. Direct exosome stimulation of peripheral human T cells detected by ELISPOT. Eur J Immunol 36 (2006) 1772-1781
17. Hwang I., Shen X., and Sprent J. Direct stimulation of naive T cells by membrane vesicles from antigen-presenting cells: distinct roles for CD54 and B7 molecules. Proc Natl Acad Sci U S A 100 (2003) 6670-6675
18. Thery C., Duban L., Segura E., Veron P., Lantz O., and Amigorena S. Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol 3 (2002) 1156-1162
19. Karlsson M., Lundin S., Dahlgren U., Kahu H., Pettersson I., and Telemo E. "Tolerosomes" are produced by intestinal epithelial cells. Eur J Immunol 31 (2001) 2892-2900
20. Chaput N., Schartz N.E., Andre F., Taieb J., Novault S., Bonnaventure P., et al. Exosomes as potent cell-free peptide-based vaccine, II: exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection. J Immunol 172 (2004) 2137-2146
21. Morse M.A., Garst J., Osada T., Khan S., Hobeika A., Clay T.M., et al. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med 3 (2005) 9
22. Aline F., Bout D., Amigorena S., Roingeard P., and Dimier-Poisson I. Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection. Infect Immun 72 (2004) 4127-4137
23. Peche H., Heslan M., Usal C., Amigorena S., and Cuturi M.C. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection. Transplantation 76 (2003) 1503-1510
24. Asher M.I., Montefort S., Bjorksten B., Lai C.K., Strachan D.P., Weiland S.K., et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 368 (2006) 733-743
25. Larche M., Akdis C.A., and Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 6 (2006) 761-771
26. *1115) segregating in a family of Turkish origin. Tissue Antigens 45 (1995) 143-144
27. Focke M., Linhart B., Hartl A., Wiedermann U., Sperr W.R., Valent P., et al. Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination. Clin Exp Allergy 34 (2004) 1525-1533
28. Thery C., Regnault A., Garin J., Wolfers J., Zitvogel L., Ricciardi-Castagnoli P., et al. Molecular characterization of dendritic cell-derived exosomes: selective accumulation of the heat shock protein hsc73. J Cell Biol 147 (1999) 599-610
29. Jahn-Schmid B., Radakovics A., Luttkopf D., Scheurer S., Vieths S., Ebner C., et al. Bet v 1142-156 is the dominant T-cell epitope of the major birch pollen allergen and important for cross-reactivity with Bet v 1-related food allergens. J Allergy Clin Immunol 116 (2005) 213-219
30. Hsu D.H., Paz P., Villaflor G., Rivas A., Mehta-Damani A., Angevin E., et al. Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides. J Immunother 26 (2003) 440-450
31. Rickert R.C. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex. Curr Opin Immunol 17 (2005) 237-243
32. Vincent-Schneider H., Stumptner-Cuvelette P., Lankar D., Pain S., Raposo G., Benaroch P., et al. Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells. Int Immunol 14 (2002) 713-722
33. Segura E., Nicco C., Lombard B., Veron P., Raposo G., Batteux F., et al. ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T cell priming. Blood 105 (2005) 216-223
34. Rialland P., Lankar D., Raposo G., Bonnerot C., and Hubert P. BCR-bound antigen is targeted to exosomes in human follicular lymphoma B-cells. Biol Cell 98 (2006) 491-501
35. Grayson M.H. Lung dendritic cells and the inflammatory response. Ann Allergy Asthma Immunol 96 (2006) 643-651 quiz 52-3, 78
36. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., and Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 6 (2007) 654-659
37. Clayton A., Turkes A., Dewitt S., Steadman R., Mason M.D., and Hallett M.B. Adhesion and signaling by B cell-derived exosomes: the role of integrins. FASEB J 18 (2004) 977-979
38. Clayton A., Harris C.L., Court J., Mason M.D., and Morgan B.P. Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59. Eur J Immunol 33 (2003) 522-531
39. Kim S.H., Lechman E.R., Bianco N., Menon R., Keravala A., Nash J., et al. Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J Immunol 174 (2005) 6440-6448
40. Kim S.H., Bianco N., Menon R., Lechman E.R., Shufesky W.J., Morelli A.E., et al. Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive. Mol Ther 13 (2006) 289-300
41. Delcayre A., Estelles A., Sperinde J., Roulon T., Paz P., Aguilar B., et al. Exosome display technology: applications to the development of new diagnostics and therapeutics. Blood Cells Mol Dis 35 (2005) 158-168